Clinical Trial Update: A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir [Phase 4]

View source ↗

Summary

Phase 4 trial updates the antiviral efficacy and safety of switching to TAF in adults with chronic hepatitis B who have suboptimal response or intolerance to en…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: HBV | Phase 4 | Status: UNKNOWN